Karn J
MRC Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, UK.
J Mol Biol. 1999 Oct 22;293(2):235-54. doi: 10.1006/jmbi.1999.3060.
Activation of cellular genes typically involves control of transcription initiation by DNA-binding regulatory proteins. The human immunodeficiency virus transactivator protein, Tat, provides the first example of the regulation of viral gene expression through control of elongation by RNA polymerase II. In the absence of Tat, initiation from the long terminal repeat is efficient, but transcription is impaired because the promoter engages poorly processive polymerases that disengage from the DNA template prematurely. Activation of transcriptional elongation occurs following the recruitment of Tat to the transcription machinery via a specific interaction with an RNA regulatory element called TAR, a 59-residue RNA leader sequence that folds into a specific stem-loop structure. After binding to TAR RNA, Tat stimulates a specific protein kinase called TAK (Tat-associated kinase). This results in hyperphosphorylation of the large subunit of the RNA polymerase II carboxyl- terminal domain. The kinase subunit of TAK, CDK9, is analogous to a component of a positive acting elongation factor isolated from Drosophila called pTEFb. Direct evidence for the role of TAK in transcriptional regulation of the HIV long terminal repeat comes from experiments using inactive mutants of the CDK9 kinase expressed in trans to inhibit transcription. A critical role for TAK in HIV transcription is also demonstrated by selective inhibition of Tat activity by low molecular mass kinase inhibitors. A second link between TAK and transactivation is the observation that the cyclin component of TAK, cyclin T1, also participates in TAR RNA recognition. It has been known for several years that mutations in the apical loop region of TAR RNA abolish Tat activity, yet this region of TAR is not required for binding by recombinant Tat protein in vitro, suggesting that the loop region acts as a binding site for essential cellular co-factors. Tat is able to form a ternary complex with TAR RNA and cyclin T1 only when a functional loop sequence is present on TAR.
细胞基因的激活通常涉及DNA结合调节蛋白对转录起始的控制。人类免疫缺陷病毒反式激活蛋白Tat,是通过RNA聚合酶II对延伸的控制来调节病毒基因表达的首个例子。在没有Tat的情况下,从长末端重复序列起始是有效的,但转录会受到损害,因为启动子与加工能力差的聚合酶结合不佳,这些聚合酶会过早地从DNA模板上脱离。转录延伸的激活发生在Tat通过与一种名为TAR的RNA调节元件特异性相互作用被招募到转录机制之后,TAR是一个由59个残基组成的RNA前导序列,可折叠成特定的茎环结构。与TAR RNA结合后,Tat会刺激一种名为TAK(Tat相关激酶)的特定蛋白激酶。这导致RNA聚合酶II羧基末端结构域的大亚基发生过度磷酸化。TAK的激酶亚基CDK9,类似于从果蝇中分离出的一种正向作用延伸因子的一个组分,称为pTEFb。TAK在HIV长末端重复序列转录调控中作用的直接证据来自使用反式表达的CDK9激酶无活性突变体来抑制转录的实验。低分子量激酶抑制剂对Tat活性的选择性抑制也证明了TAK在HIV转录中的关键作用。TAK与反式激活之间的第二个联系是观察到TAK的细胞周期蛋白组分细胞周期蛋白T1也参与TAR RNA识别。多年来已知TAR RNA顶端环区域的突变会消除Tat活性,但TAR的这个区域在体外并非重组Tat蛋白结合所必需,这表明环区域充当必需细胞辅助因子的结合位点。只有当TAR上存在功能性环序列时,Tat才能与TAR RNA和细胞周期蛋白T1形成三元复合物。